Related Experiment Videos
Studies on antitumor activity of prumycin. IV. Effect of prumycin on mouse immune system
Abstract:
The effect of prumycin on the mouse immune system was studied. Prumycin at a dose of 75 mg/kg (1/2LD50) showed essentially no suppression of hemolytic plaque forming cells (PFC) against sheep red blood cells (SRBC) when it was administered on day 0, 1 or 2. However, a weak suppression was observed by administration of prumycin on day 3. Also a remarkable suppression of PFC was demonstrated when mouse spleen cells were pre-incubated with prumycin at the concentration over 62.5 mg/kg in vitro. The delayed-type hypersensitivity reaction against SRBC was remarkably suppressed by cyclophosphamide, but it was not much by prumycin, except by administration on the day of elicitation. Prumycin of a high concentration inhibited an uptake of 3H-thymidine by mouse spleen lymphocytes incubated with or without phytohemagglutinin, but that of a low concentration, 1.9 approximately 0.03 mcg/ml, slightly increased the blastogenic stimulation of lymphocytes.
Insights
Prumycin minimally impacts the mouse immune system, showing slight suppression of plaque-forming cells (PFC) only when administered late. High concentrations inhibited lymphocyte proliferation in vitro.
Area of Science:
- Immunology
- Pharmacology
Background:
- Prumycin is an antimicrobial agent.
- Its effects on the mammalian immune system are not fully understood.
Purpose of the Study:
- To investigate the immunomodulatory effects of prumycin in mice.
- To assess prumycin's impact on humoral and cellular immune responses.
Main Methods:
- Mice were administered prumycin at various time points relative to sheep red blood cell (SRBC) immunization.
- Hemolytic plaque-forming cell (PFC) assays were performed.
- Delayed-type hypersensitivity (DTH) reactions were measured.
- In vitro lymphocyte proliferation assays using 3H-thymidine uptake were conducted.
Main Results:
- Prumycin (75 mg/kg) showed minimal suppression of PFC when given early (days 0-2), with weak suppression on day 3.
- Significant PFC suppression occurred when spleen cells were pre-incubated with prumycin (>62.5 mg/kg) in vitro.
- Prumycin had little effect on DTH reactions, unlike cyclophosphamide.
- High prumycin concentrations inhibited lymphocyte proliferation, while low concentrations (1.9 ± 0.03 mcg/ml) slightly enhanced it.
Conclusions:
- Prumycin exhibits dose- and time-dependent immunomodulatory effects.
- In vitro studies suggest a direct impact on lymphocyte function.
- Further research is needed to elucidate the precise mechanisms of prumycin's interaction with the immune system.